Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease

Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease

The aims of this study were: to examine regional rates of change in tau-PET uptake and grey matter volume in atypical Alzheimer's disease (AD); to investigate the role of age in such changes; to describe multimodal regional relationships between tau accumulation and atrophy. Thirty atypical AD...

Full description

Bibliographic Details
Main Authors:	Irene Sintini, Peter R. Martin, Jonathan Graff-Radford, Matthew L. Senjem, Christopher G. Schwarz, Mary M. Machulda, Anthony J. Spychalla, Daniel A. Drubach, David S. Knopman, Ronald C. Petersen, Val J. Lowe, Clifford R. Jack, Jr, Keith A. Josephs, Jennifer L. Whitwell
Format:	Article
Language:	English
Published:	Elsevier 2019-01-01
Series:	NeuroImage: Clinical
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213158219301731

Similar Items

Distinct brain iron profiles associated with logopenic progressive aphasia and posterior cortical atrophy
by: Neha Atulkumar Singh, et al.
Published: (2022-01-01)

Altered structural and functional connectivity in Posterior Cortical Atrophy and Dementia with Lewy bodies
by: Neha Atulkumar Singh, et al.
Published: (2024-04-01)

Comparative assessment of regional tau distribution by Tau-PET and Post-mortem neuropathology in a representative set of Alzheimer's & frontotemporal lobar degeneration patients.
by: Rodolfo G Gatto, et al.
Published: (2023-01-01)

Elevated medial temporal lobe and pervasive brain tau‐PET signal in normal participants
by: Val J. Lowe, et al.
Published: (2018-01-01)

Direct comparison between 18F-Flortaucipir tau PET and quantitative susceptibility mapping in progressive supranuclear palsy
by: Ryota Satoh, et al.
Published: (2024-02-01)

18F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus
by: Ryan A. Townley, et al.
Published: (2018-01-01)

FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type.
by: Ajay Madhavan, et al.
Published: (2013-01-01)

TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration
by: Marina Buciuc, et al.
Published: (2022-01-01)

Face recognition from research brain PET: An unexpected PET problem
by: Christopher G. Schwarz, et al.
Published: (2022-09-01)

MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous
by: Keith A. Josephs, et al.
Published: (2020-05-01)

White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition
by: Sheelakumari Raghavan, et al.
Published: (2022-02-01)

Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes
by: Jordan D. Marks, et al.
Published: (2021-12-01)

FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD
by: Kejal Kantarci, et al.
Published: (2021-01-01)

Clinical and MRI models predicting amyloid deposition in progressive aphasia and apraxia of speech
by: Jennifer L. Whitwell, et al.
Published: (2016-01-01)

Relationship Between Risk Factors and Brain Reserve in Late Middle Age: Implications for Cognitive Aging
by: Bryan J. Neth, et al.
Published: (2020-01-01)

Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology
by: Daniel J. Figdore, et al.
Published: (2024-01-01)

Considerations for Performing Level-2 Centiloid Transformations for Amyloid PET SUVR values
by: Christopher G. Schwarz, et al.
Published: (2018-05-01)

Relationships between β-amyloid and tau in an elderly population: An accelerated failure time modelww
by: Terry M. Therneau, Ph.D., et al.
Published: (2021-11-01)

Influences of amyloid-β and tau on white matter neurite alterations in dementia with Lewy bodies
by: Elijah Mak, et al.
Published: (2024-04-01)

Comparison of [18F]Flutemetamol and [11C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals
by: Val J. Lowe, et al.
Published: (2017-01-01)

Atypical clinical variants of Alzheimer’s disease: are they really atypical?
by: Jennifer L. Whitwell
Published: (2024-02-01)

Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation
by: Christopher G. Schwarz, et al.
Published: (2021-09-01)

Assessing network degeneration and phenotypic heterogeneity in genetic frontotemporal lobar degeneration by decoding FDG-PET
by: Nick Corriveau-Lecavalier, et al.
Published: (2024-01-01)

Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research
by: Christopher G. Schwarz, et al.
Published: (2023-01-01)

Spatial patterns of elevated magnetic susceptibility in progressive apraxia of speech
by: Ryota Satoh, et al.
Published: (2023-01-01)

Automated detection of imaging features of disproportionately enlarged subarachnoid space hydrocephalus using machine learning methods
by: Nathaniel B. Gunter, et al.
Published: (2019-01-01)

P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status
by: Michelle R. Campbell, et al.
Published: (2021-01-01)

CSF dynamics as a predictor of cognitive progression
by: Petrice M. Cogswell, et al.
Published: (2021-05-01)

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
by: Tessa Timmers, et al.
Published: (2019-07-01)

Disrupted functional connectivity in primary progressive apraxia of speech
by: Hugo Botha, et al.
Published: (2018-01-01)

Tau and atrophy: domain-specific relationships with cognition
by: Leonardino A. Digma, et al.
Published: (2019-07-01)

Consensus recommendations for clinical assessment tools for the diagnosis of posterior cortical atrophy syndrome from the Atypical AD PIA of ISTAART
by: Victoria S. Pelak, et al.
Published: (2023-07-01)

Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels
by: Melissa E. Murray, et al.
Published: (2022-12-01)

Cross–scanner harmonization methods for structural MRI may need further work: A comparison study
by: Robel K. Gebre, et al.
Published: (2023-04-01)

Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer’s disease continuum: biological and methodological perspectives from disease heterogeneity
by: Rosaleena Mohanty, et al.
Published: (2023-02-01)

Evidence against a temporal association between cerebrovascular disease and Alzheimer’s disease imaging biomarkers
by: Petrice M. Cogswell, et al.
Published: (2023-05-01)

Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants
by: Jennifer L. Whitwell, et al.
Published: (2020-01-01)

Imaging pathological tau in atypical parkinsonisms: A review
by: Anastassia M. Mena, et al.
Published: (2022-01-01)

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
by: Shi-Dong Chen, et al.
Published: (2021-09-01)

Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers
by: Petrice M. Cogswell, et al.
Published: (2021-01-01)